Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum (PG) in Clinical Trials: A Delphi Consensus on Behalf of the Understanding PG: Review and Assessment of Disease Effects (UPGRADE) Group-Reference-Cited by-同舟云学术

Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum (PG) in Clinical Trials: A Delphi Consensus on Behalf of the Understanding PG: Review and Assessment of Disease Effects (UPGRADE) Group

Published:2023-12 Issue: Volume: Page:
ISSN:0022-202X
Container-title:Journal of Investigative Dermatology
language:en
Short-container-title:Journal of Investigative Dermatology

Author:

Kamal Kanika,Xia Eric,Li Sara J.,Alavi Afsaneh,Cogen Anna L.,Firooz Alireza,Marzano Angelo V.,Kaffenberger Benjamin H.,Sibbald Cathryn,Fernandez Anthony P.,Callen Jeffrey P.,Dissemond Joachim,Renato V Gontijo João,Shams Kave,Gerbens Louise A.,French Lars E.,Gould Lisa J.,Bissonnette Robert,Shaigany Sheila,Tolkachjov Stanislav,Yamamoto Toshiyuki,Wei-Ting Huang William,Ortega-Loayza Alex G.,Mostaghimi Arash

Publisher

Elsevier BV

Subject

Cell Biology,Dermatology,Molecular Biology,Biochemistry

Reference20 articles.

1. The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum;Ashchyan;JAMA Dermatol,2018

2. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial;Brooklyn;Gut,2006

3. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME);Chalmers;Br J Dermatol,2014

4. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial;Chaudhari;Lancet,2001

5. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines;Crow;Transpl Int,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Pyoderma Gangrenosum;Dermatologic Clinics;2023-12